fda glp-1 warning letters september 2025 news Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA sends warning letter after

Circulation 145(18):e895-1032 Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G et al (2020) A multinational registry to study the characteristics and outcomes of heart failure patients: the global congestive heart failure (G-CHF) registry

They help control diabetes and aid in weight loss, boosting health

Dose escalation and what to expect at each level GLP-1 therapy always begins with a lower dose and escalates over weeks to months

When GLP-1 RAs are not used concomitantly with a sulphonylurea or insulin, routine glucose monitoring is unnecessary due to the low risk of developing hypoglycemia

Understanding how naltrexone differs from naloxone helps avoid confusion about these similar-sounding medications